- Title
- Temporal trends in the cost of adverse events (AEs) in patients with primary advanced or recurrent endometrial cancer (pA/R EC) in the ENGOT-EN-6-NSGO/GOG-3031/RUBY trial
- Creators
- Elizabeth Lokich - Providence CollegeManasvi Sundar - Analysis Group, Los Angeles, CA, United StatesJinlin Song - Analysis Group, Los Angeles, CA, United StatesSolomon Lubinga - GSK, Collegeville, PA, United StatesKeith Betts - Analysis Group, Los Angeles, CA, United StatesLyndsay Willmott - Arizona Center for Cancer Care, Phoenix, AZ, United States
- Publication Details
- Gynecologic oncology, Vol.208, pp.S99-S100
- Publisher
- Elsevier Inc
- Identifiers
- 991006271510402656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Temporal trends in the cost of adverse events (AEs) in patients with primary advanced or recurrent endometrial cancer (pA/R EC) in the ENGOT-EN-6-NSGO/GOG-3031/RUBY trial
Gynecologic oncology, Vol.208, pp.S99-S100
05/2026
Metrics
1 Record Views